Headlines (most recent)
- UNICEF: More than 29 million babies born into conflict in 2018. 20 Sep 2019
- IFRC: Humanitarian aid to cost US$20 billion per year by 2030 in a warmer world. 19 Sep 2019
- WHO: World at risk of pandemics, warns global monitoring board. 19 Sep 2019
- UNICEF: Every 11 seconds, a pregnant woman or newborn dies somewhere around the world. 19 Sep 2019
- FAO: FAO report says 41 countries need food assistance. 19 Sep 2019
Most read reports
- FAO: Crop Prospects and Food Situation, No. 3, September 2019. 19 Sep 2019
- WHO: A World at Risk : Annual report on global preparedness for health emergencies - Global Preparedness Monitoring Board [EN/AR/RU/ZH]. 19 Sep 2019
- ICRC: Explosive weapons in cities: Civilian devastation and suffering must stop. 18 Sep 2019
- IEP: Global Peace Index 2019. 12 Jun 2019
- UNICEF: Surviving birth: Every 11 seconds, a pregnant woman or newborn dies somewhere around the world. 19 Sep 2019
SOUTH AFRICA, June 13, 2019 – Today, the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial* released study results comparing the relative risk of HIV acquisition among women using one of the following three contraceptive methods: the injectable contraceptive DMPA-IM; the Jadelle LNG-implant; and a copper intrauterine device, or IUD.
Event in Oslo in November aims to urgently raise funds to save the lives of 38 million women, children and adolescents in 50 countries
BRUSSELS (25 January 2018) - The Bill & Melinda Gates Foundation today announced their commitment to contribute to the EU's External Investment Plan.
Gates Foundation funding complements investments from the European Commission ($318M/€270M) also announced today, bringing total agriculture R&D commitments to over $600M (around €525M)
Ending Cholera—A Global Roadmap to 2030 operationalises the new global strategy for cholera control at the country level and provides a concrete path toward a world in which cholera is no longer a threat to public health. By implementing the strategy between now and 2030, the Global Task Force on Cholera Control (GTFCC) partners will support countries to reduce cholera deaths by 90 percent. With the commitment of cholera-affected countries, technical partners, and donors, as many as 20 countries could eliminate disease transmission by 2030.
New York – A breakthrough pricing agreement has been announced which will accelerate the availability of the first affordable, generic, single-pill HIV treatment regimen containing dolutegravir (DTG) to public sector purchasers in low- and middle-income countries (LMICs) at around US$75 per person, per year. The agreement is expected to accelerate treatment rollout as part of global efforts to reach all 36.7 million people living with HIV with high-quality antiretroviral therapy.
Authors: Valerie Nkamgang Bemo, Dilwonberish Aberra, Jamie M. Zimmerman, Amanda Lanzarone, David Lubinski
Dubai, UAE, August 29, 2016 – The International Center for Biosaline Agriculture (ICBA) launched today the design phase of a new major regional program to empower young Arab women scientists and leaders in agricultural research and development.
Funded by the Islamic Development Bank (IsDB) and the Bill & Melinda Gates Foundation, the design phase will lay the groundwork for the Young Arab Women Scientists Leadership (Tamkeen) Program, the first of its kind in the Middle East and North Africa (MENA) region.
WHAT IS DREAMS?
DREAMS is an ambitious partnership to reduce new HIV infections among adolescent girls and young women in 10 sub-Saharan African countries. The goal of DREAMS is to help girls develop into Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe women.
DREAMS is responding to the alarming fact that, every year, 380,000 adolescent girls and young women are infected with HIV—7,300 every week, over 1,000 every day. Girls and young women account for 71 percent of new HIV infections among adolescents in sub-Saharan Africa.
Despite great momentum, immediate acceleration needed to reach Family Planning 2020 goal
DREAMS is an ambitious partnership to reduce HIV infections among adolescent girls and young women in 10 sub-Saharan African countries.
The goal of DREAMS is to help girls develop into Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe women.
Girls and young women account for 71 percent of new HIV infections among adolescents in sub-Saharan Africa.
Melinda Gates makes announcement in Brussels during European Development Days
SEATTLE (May 6, 2015) – At its Global Partners Forum, the Bill & Melinda Gates Foundation will announce the Child Health and Mortality Prevention Surveillance Network (CHAMPS), a network of disease surveillance sites in developing countries. These sites will help gather better data, faster, about how, where and why children are getting sick and dying. This data will help the global health community get the right interventions to the right children in the right place to save lives.
DAVID J. OLSON
“In Mali, at a family planning clinic, I saw a woman who couldn't afford the services so the clinic staff were sending her home. I said to the staff ‘Do you have a sliding scale [for paying the fee]? She's poor. She needs this. It's good for her. It's good for your country.’”
A challenge stands before us: ensuring immunisation of the world’s poorest children.If we, as global citizens can meet it, we will help protect the lives of millions in places too poor to afford vaccines.
Despite remarkable progress made by Gavi, the Vaccine Alliance in helping to immunise half a billion children since 2000, nearly one-in-five children are still missing out, such that every year, 1.5 million still die from vaccine-preventable diseases.
M. Sapin, ministre des Finances et des Comptes publics, Annick Girardin, secrétaire d’État chargée du Développement et de la Francophonie et la Fondation Bill & Melinda Gates annoncent aujourd’hui un partenariat via un mécanisme innovant permettant d'accroître les financements à destination des programmes de vaccination et d’immunisation et d’améliorer l’efficience du secteur de la santé au Sahel. Cette initiative pilote s’élèvera à 100 millions d'euros sur la période 2016-2020.
Michel Sapin, Minister of finance and public accounts, Mrs Annick Girardin, Minister of State for Development and Francophony and the Bill & Melinda Gates Foundation announce today their collaboration on an innovative mechanism aimed at increasing funding to support vaccination and immunization programs, and to improve the efficiency of the health sector, in the Sahel region. The pilot initiative will amount to 100 million euros over the period 2016-2020.
For 22-year-old Claribel, making ends meet is a challenge. She and her family live in a remote, marginalized community in the Dominican Republic with little access to health services and clean water – conditions which place Claribel’s family at risk for contracting neglected tropical diseases (NTDs) such as intestinal worms. Claribel’s three children, Altagracia (6), Wardin (3) and Nismael (2), eat arroz con habichuelas (rice and beans) for nearly every meal, and they rarely have access to essential protein and vegetables.
In an address to American Society of Tropical Medicine and Hygiene, Bill Gates says that the Ebola epidemic underscores the urgent need for R&D to stay ahead of emerging disease threats, and declares that new drugs, diagnostics, and vaccines can eradicate malaria by the middle of the 21st Century.
Media Contact 206-709-3400 email@example.com
PARIS (October 14, 2014) – The Bill & Melinda Gates Foundation today announced that Agence de Médecine Préventive (AMP) has received the third annual Gates Vaccine Innovation Award in recognition of EPIVAC, an on-the-job training program for district medical officers to improve immunization program performance in 11 Francophone African countries: Benin, Burkina Faso, Cameroon, Central African Republic, Côte d’Ivoire, Guinea, Mali, Mauritania, Niger, Senegal and Togo.